Leucovorin (LV)
Leucovorin (LV) is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
Clinical Trials (9)
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
Colorectal Cancer RECHALLENGE
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9